A DECADE OF SILENCE: HOW NIGERIA’S POLICE FORCE LEFT APPROXIMATELY 1,850 GRADUATE OFFICERS IN A PROLONGED PROMOTION PROCESS

 Africa's Resources and Leadership A Blessing or a Curse? The HIV Crisis and Nigeria’s Role in Leading by Example

Africa is a continent rich in natural and human resources, yet it remains heavily dependent on foreign aid. This paradox raises a critical question: Are Africa’s resources a blessing or a curse? The leadership crisis, coupled with mismanagement of resources, continues to undermine Africa’s potential. The continent is not inherently poor—it is resource-rich but leadership-deficient. Corruption, inadequate policies, and a lack of visionary leadership have stalled progress. Instead of waiting for foreign donors to dictate healthcare policies, African governments must take full responsibility for their citizens’ well-being, particularly in healthcare, where millions rely on external support for survival. A glaring example is the ongoing struggle against HIV/AIDS.

HIV can be deadly without antiretroviral therapy (ART). However, thanks to medical advancements, people with HIV can now live longer, healthier lives. Modern treatments, including once-a-day pills, have significantly improved the quality of life for those infected. Despite these advancements, the cost of HIV care remains high. Studies estimate that the lifetime cost of HIV treatment ranges between $1,800 and $4,500 per month, with about 60% of expenses attributed to ART medications.

The price of treatment varies depending on factors such as drug brand and availability. For example, the wholesale price of Truvada (emtricitabine/tenofovir disoproxil fumarate) is nearly $1,700 for a 30-day supply in the U.S., whereas Epivir (lamivudine) costs around $400. Given these high costs, Africa’s dependence on foreign aid, particularly through programs like the President’s Emergency Plan for AIDS Relief (PEPFAR), has been crucial in ensuring access to life-saving medication.

The Trump administration’s executive order on foreign aid led to a 90-day suspension of PEPFAR funds, putting millions of lives at risk. The U.S. State Department halted the disbursement of PEPFAR funds, affecting over 20.6 million people who rely on the program for treatment. Nigeria, which has one of the highest HIV burdens globally—with approximately two million people living with HIV—has historically depended on PEPFAR for medication and healthcare infrastructure. The program has contributed over $6 billion to Nigeria’s national HIV/AIDS response.

However, the suspension of PEPFAR disrupted critical medical supplies, canceled patient appointments, and forced clinics to turn away HIV-positive individuals. Moreover, Republican opposition to PEPFAR’s reauthorization, citing claims that the program promotes abortions, further jeopardized its future. If PEPFAR were to end permanently, millions of lives could be lost in Africa alone over the next decade.

The withdrawal of PEPFAR funds might have a devastating impact on healthcare systems across Africa:

Abrupt interruptions in treatment: If people with HIV are left without access to medication, their viral load will increase, raising the risk of transmission.

Mother-to-child transmission: Approximately one in three untreated pregnant women with HIV may pass the virus to their babies.

Drug-resistant strains of HIV: Interrupted treatments can lead to the emergence of resistant HIV strains, posing a global health threat.

Hospitals, clinics, and medical facilities that depend on U.S. funding for operations will suffer greatly.

Reports indicate that U.S. contractors working with USAID received orders to immediately halt work related to HIV, malaria, and tuberculosis. This policy shift disrupted drug shipments to clinics, leaving patients stranded. PEPFAR’s data systems were also shut down, blocking access to vital reports and analytical tools used to track treatment progress.

With foreign aid dwindling, African nations, particularly Nigeria, must take decisive action to secure sustainable healthcare solutions. Instead of relying on external donors, Nigeria should invest in local pharmaceutical production, strengthen healthcare policies, and allocate more funds to medical research.

Nigeria should encourage local pharmaceutical manufacturing to reduce dependence on imported HIV medications and lower costs.

Increase healthcare funding by allocating a higher percentage of the national budget to the health sector and establish an independent HIV/AIDS fund to provide financial security for long-term treatment programs.

Leverage in corporate social responsibility (CSR) initiatives from Nigerian businesses to support HIV and other treatment programs.

Nigeria should expand grassroots healthcare initiatives to ensure HIV-positive individuals in remote areas receive continuous treatment.

Train more healthcare workers and equip local clinics to improve accessibility to ART medications.

Establish regional drug manufacturing hubs through ECOWAS member states to support West Africa’s healthcare needs.

The suspension of PEPFAR funding underlines the vulnerability of African nations that rely heavily on foreign aid. However, the deeper issue is not just external dependence but poor leadership and mismanagement of resources.

The question remains: Is Africa poor, or are its leaders failing to harness the continent’s wealth effectively? Nigeria, with its vast resources and influence, must step up and set an example by building a self-sufficient healthcare system.

The HIV/AIDS crisis serves as a stark reminder of Africa’s overreliance on foreign aid. The suspension of PEPFAR funding has left millions at risk, exposing the fragility of Africa’s healthcare systems. Nigeria, as a leader, must take proactive steps to prioritize healthcare investments, encourage domestic drug production, and implement sustainable healthcare policies.

Africa’s resources can be a blessing if managed wisely, but they remain a curse when misgoverned. It is time for African leaders to shift from dependency to self-reliance and take charge of their nations’ futures. Only then can the continent break free from the cycle of external aid and build a buoyant, independent healthcare system.

Daniel Okonkwo for Profile International Human Rights Advocate.